ISS backs all six Anavex director nominees ahead of annual meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. AXP
8. SPY
9. CVS
10. UNH

Go back to ISS backs all six Anavex director nominees ahead of annual meeting

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees

September 14, 2026 8:30 AM EDT

ISS Recognizes There is No Case for Change

Anavex Urges Stockholders to Follow ISS Recommendation and Vote FOR ALL Six Director Nominees on the WHITE Proxy Card Today

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system diseases with high unmet medical needs, today announced that leading independent proxy advisory firm Institutional Shareholder Services (ISS) has recommended that Anavex stockholders vote on the WHITE proxy card FOR all six of the Companys highly qualified director nominees... More